Royalty Pharma plc

RPRX

$56.63

Name : Royalty Pharma plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $32,722,823,168.00

EPSttm : 1.88

Royalty Pharma plc

$56.63

0.93%

$0.53

RPRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.79

Margin Of Safety %

Put/Call OI Ratio

0.15

EPS Next Q Diff

0.23

EPS Last/This Y

3.55

EPS This/Next Y

0.39

Price

57.16

Target Price

65.71

Analyst Recom

1.5

Performance Q

0.42

Upside

-27.6%

Beta

0.38

Ticker: RPRX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-09-08	RPRX	60.58	0.20	5.10	10263
2026-09-09	RPRX	60.59	0.26	1.42	10766
2026-09-10	RPRX	58.75	0.25	0.56	10763
2026-09-11	RPRX	58.6	0.26	0.22	10773
2026-09-14	RPRX	59.04	0.26	17.67	10776
2026-09-15	RPRX	58.45	0.24	1.27	10654
2026-09-16	RPRX	58.47	0.24	0.29	10678
2026-09-17	RPRX	58.93	0.24	0.26	10682
2026-09-18	RPRX	58.42	0.24	0.21	10705
2026-09-21	RPRX	58.46	0.15	0.05	8442
2026-09-22	RPRX	58.51	0.14	0.01	8669
2026-09-23	RPRX	57.66	0.14	1.20	8733
2026-09-24	RPRX	58.29	0.14	0.12	8741
2026-09-25	RPRX	58.23	0.14	0.15	8761
2026-09-28	RPRX	58.38	0.14	0.22	8778
2026-09-29	RPRX	58.22	0.14	0.07	8780
2026-09-30	RPRX	58.38	0.14	0.39	8790
2026-10-01	RPRX	57.65	0.14	2.00	8817
2026-10-02	RPRX	57.12	0.15	0.46	8821
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-09-08	RPRX	60.58	-0.2	239.1	5.33
2026-09-09	RPRX	60.58	-0.2	324.7	5.33
2026-09-10	RPRX	58.75	-0.2	276.6	5.33
2026-09-11	RPRX	58.60	0.6	321.0	5.34
2026-09-14	RPRX	59.05	0.6	337.8	5.34
2026-09-15	RPRX	58.47	0.6	309.5	5.34
2026-09-16	RPRX	58.47	0.6	309.5	5.34
2026-09-17	RPRX	58.92	0.6	337.3	5.34
2026-09-18	RPRX	58.39	0.6	310.7	5.34
2026-09-21	RPRX	58.45	0.6	326.1	5.34
2026-09-22	RPRX	58.53	0.6	327.2	5.34
2026-09-23	RPRX	57.65	0.6	301.9	5.34
2026-09-24	RPRX	58.30	0.6	342.9	5.34
2026-09-25	RPRX	58.22	0.6	323.1	5.34
2026-09-28	RPRX	58.40	0.6	326.8	5.34
2026-09-29	RPRX	58.22	0.6	318.1	5.34
2026-09-30	RPRX	58.36	0.6	325.6	5.34
2026-10-01	RPRX	57.63	0.6	303.9	5.34
2026-10-02	RPRX	57.16	0.6	292.0	5.34
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-09-08	RPRX	-2.10	1.39	2.78
2026-09-09	RPRX	-1.63	1.39	2.78
2026-09-10	RPRX	-1.63	1.39	2.78
2026-09-11	RPRX	-1.63	1.39	2.86
2026-09-14	RPRX	-1.64	1.40	2.85
2026-09-15	RPRX	-1.64	1.40	2.85
2026-09-16	RPRX	-1.64	1.40	2.85
2026-09-17	RPRX	-1.64	1.40	2.85
2026-09-18	RPRX	-1.64	1.40	2.85
2026-09-21	RPRX	-1.64	1.38	2.85
2026-09-23	RPRX	-1.64	1.38	2.85
2026-09-24	RPRX	-1.64	1.38	2.85
2026-09-25	RPRX	-1.91	1.38	2.79
2026-09-28	RPRX	-1.81	1.37	2.79
2026-09-29	RPRX	-1.81	1.37	2.79
2026-09-30	RPRX	-1.82	1.37	2.79
2026-10-01	RPRX	-1.83	1.37	2.79
2026-10-02	RPRX	-1.83	1.37	2.79
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

1.32

Avg. EPS Est. Current Quarter

1.18

Avg. EPS Est. Next Quarter

1.55

Insider Transactions

-1.83

Institutional Transactions

1.37

Beta

0.38

Average Sales Estimate Current Quarter

691

Average Sales Estimate Next Quarter

736

Fair Value

75.79

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

11.2

Max Drawdown 5-Year %

-42

Target Price

65.71

P/E

30.43

Forward P/E

9.97

PEG

0.97

P/S

12.96

P/B

3.73

P/Free Cash Flow

10.91

EPS

1.88

Average EPS Est. Cur. Y

5.34

EPS Next Y. (Est.)

5.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.13

Relative Volume

0.75

Return on Equity vs Sector %

-14.3

Return on Equity vs Industry %

5.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

292

◆ RPRX Healthcare

$57.16

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

16/20

Pullback

25/25

Volume

9/15

Valuation

13/20

TP/AR

4/10

Options

7/10

RSI

36.9

Range 1M

2.6%

Sup Dist

0.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

16/25

Growth

11/30

Estimates

7/20

Inst/Vol

5/15

Options

10/10

EPS Yr

10.6%

EPS NY

7.3%

52W%

75.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +73% upside

Quality

10/30

Valuation

24/30

Growth

10/25

Stability

6/10

LT Trend

1/5

Upside

+73%

Quality

MoS

33%

RPRX — P/E HistoricalBiotechnology

Royalty Pharma plc

Sector: Healthcare

Industry: Biotechnology

Employees: 100

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

RPRX

Latest News

—

Caricamento notizie per RPRX…

stock quote shares RPRX – Royalty Pharma plc Stock Price stock today

news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025

marketwatch RPRX – Royalty Pharma plc yahoo finance google finance

stock history RPRX – Royalty Pharma plc invest stock market

stock prices RPRX premarket after hours

ticker RPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y